-
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de...
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de Intensive Care (ANACOR-IC) -
Convalescent plasma as a treatment for high-risk outpatients administered...
Convalescent plasma as a treatment for high-risk outpatients administered within 7 days after COVID-19 disease onset (CoV-Early) -
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de...
ANAkinra voor de behandeling van CORonavirus infectious disease 2019 op de Intensive Care (ANACOR-IC) -
Convalescent plasma as a treatment for high-risk outpatients administered...
Convalescent plasma as a treatment for high-risk outpatients administered within 7 days after COVID-19 disease onset (CoV-Early)